in Health care
Merck-Moderna vaccine helps keep patients free from skin cancer
An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44 percent compared with Merck’s immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday. The findings suggest that adding a personalized cancer vaccine based on […] More
